TrialBlood2015
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.
Alan K Burnett et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
140 papers cite itlatest 60 shown
this paperpooled ittrialcites it